翰宇药业：拟向特定对象发行A股股票

Group 1 - The company, Hanyu Pharmaceutical, announced that it will hold a board and supervisory board meeting on September 25, 2025, to review the proposal for a specific issuance of A-shares [1] - The relevant proposal and announcement have been disclosed on the Giant Tide Information Network [1] - The issuance of shares is subject to approval by the Shenzhen Stock Exchange and registration consent from the China Securities Regulatory Commission [1]